Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Amazon.com, Inc. (AMZN) Needs More Time: Jordan Crook

Online retail giant and tech major Amazon.com, Inc. (NASDAQ:AMZN) reported its second quarter earnings yesterday after market close. In the light of the selling pressure that the stock has come under today on the back of a wider than expected second quarter losses, Jordan Crook, who is a writer for TechCrunch, told CNBC on its “Earnings Central” programming segment that the “shareholders should remain patient with Amazon.com, Inc. (NASDAQ:AMZN) as it shapes up to “making a land-grab” in order to assure itself of future yields.

Amazon.com, Inc. (NASDAQ:AMZN)

Answering the question if investors are losing patience with Amazon.com, Inc. (NASDAQ:AMZN) as indicated by the share price slide seen yesterday, Crook responded: “It absolutely seems to be the case.” She went on to add that:

“It is slightly curious to me, investors for a long time have been patient with Amazon.com, Inc. (NASDAQ:AMZN), because this has traditionally been the go to strategy and they have continuously posted double digit revenue growth quarter over quarter for maybe 50 quarters straight.”

She went on to analyze the recent investor discontent by stating that: “it’s not to state that investors are not loving Amazon.com, Inc. (NASDAQ:AMZN), it’s just investors are getting a little bit antsy and wanting to see more profits and may be less spending.” Crook advocated that investors should remain patient with Amazon.com, Inc. (NASDAQ:AMZN) because it “has to invest in order to yield later.”

When pointed out that Amazon.com, Inc. (NASDAQ:AMZN) market cap had fallen behind Facebook Inc (NASDAQ:FB)’s yesterday, Crook rationalized that Amazon.com, Inc. (NASDAQ:AMZN) has made in the recent past huge investments to lower the margin on its hardware and has also invested close to $100 million in developing digital content, which should result in the firm being able to regain lost ground in due course.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!